Results for “”

Entry Author Date Location
AbCellera Raises $105M to Advance Antibody Discovery Operations 05/27/20 Seattle
New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury 05/27/20 Boston
Gilead Gains Foothold in Solid Tumors With $375M, 10-Year Arcus Bio Pact 05/27/20 San Francisco
Merck Outlines COVID-19 Ambitions With Buyout Deal, Collaborations 05/27/20 New York
Insitro Adds $143M to Fuel Machine Learning-Driven Drug Development 05/26/20 San Francisco
Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments 05/26/20 San Diego
COVID-19 Sparks New Opportunities for Digital Health Companies 05/26/20 Boston
Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq 05/22/20 National
FDA Approves Evofem’s “On-Demand” Non-Hormonal Birth Control Gel 05/22/20 National
Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More 05/22/20 National
AMAG Pharma Sells Off Women’s Health Product in Planned Divestment 05/22/20 Boston
Sunovion Drug Gets FDA Nod for Treating Parkinson’s “Off” Episodes 05/21/20 Boston
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic 05/21/20 Boston
Vividion Gets $135M in Collaboration With Roche on Protein Degradation 05/20/20 San Diego
Applied Molecular Plots IPO to Back Transport of Biologic Drugs to Gut 05/20/20 San Francisco
Explore San Diego’s Precision Medicine and Genomics Sector in Xconomy’s New Podcast and Special Report 05/20/20 National
With $30M, Octant Launches Synthetic Bio Search for Multi-Target Drugs 05/20/20 San Francisco
Amplyx Adds Cash from Pfizer, Adage as Funding Round Tops $90M 05/19/20 San Diego
Rallybio Lands $145M to Alter Course of FNAIT and More Rare Diseases 05/19/20 New York
Early COVID-19 Vaccine Data Sets Up Moderna for Next Stages of Testing 05/18/20 Boston
Antibiotic Development: HHS Not Yet Sold on “Pull” Incentives 05/16/20 National
Deciphera Pharmaceuticals Wins Early FDA Nod for GI Cancer Treatment 05/15/20 Boston
ADC’s $233M IPO Brings It to NYSE With Cancer Drug Launch on Horizon 05/15/20 New York
Bio Roundup: FDA Dings BMS, Genfit’s Fall, Alexion’s Activist & More 05/15/20 National
From Overseas, Legend Biotech and Calliditas Therapeutics Eye the Nasdaq 05/15/20 New York
Biotech “Mapmaker” Immunai Launches With $20M to Chart the Immune System 05/14/20 New York
Boehringer Ingelheim Acquires Northern Biologics’ Preclinical Pipeline 05/14/20 New York
BCMA Delay: FDA Refuses Review of Bristol Drug, Asks for More Info 05/13/20 New York
QurAlis Hauls In $42M to Move New ALS Therapies Into Human Testing 05/13/20 Boston
Oncology Biotech CEO Activates “Latent Viral Side” Against COVID-19 05/13/20 San Diego
Page 1 of 1966 next page »